Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Vendor Neutral Archive (VNA) and PACS
1.2 Key Market Segments
1.2.1 Vendor Neutral Archive (VNA) and PACS Segment by Type
1.2.2 Vendor Neutral Archive (VNA) and PACS Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Vendor Neutral Archive (VNA) and PACS Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Vendor Neutral Archive (VNA) and PACS Market Competitive Landscape
3.1 Global Vendor Neutral Archive (VNA) and PACS Revenue Market Share by Company (2019-2024)
3.2 Vendor Neutral Archive (VNA) and PACS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Vendor Neutral Archive (VNA) and PACS Market Size Sites, Area Served, Product Type
3.4 Vendor Neutral Archive (VNA) and PACS Market Competitive Situation and Trends
3.4.1 Vendor Neutral Archive (VNA) and PACS Market Concentration Rate
3.4.2 Global 5 and 10 Largest Vendor Neutral Archive (VNA) and PACS Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Vendor Neutral Archive (VNA) and PACS Value Chain Analysis
4.1 Vendor Neutral Archive (VNA) and PACS Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Vendor Neutral Archive (VNA) and PACS Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Vendor Neutral Archive (VNA) and PACS Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vendor Neutral Archive (VNA) and PACS Market Size Market Share by Type (2019-2024)
6.3 Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Type (2019-2024)
7 Vendor Neutral Archive (VNA) and PACS Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vendor Neutral Archive (VNA) and PACS Market Size (M USD) by Application (2019-2024)
7.3 Global Vendor Neutral Archive (VNA) and PACS Market Size Growth Rate by Application (2019-2024)
8 Vendor Neutral Archive (VNA) and PACS Market Segmentation by Region
8.1 Global Vendor Neutral Archive (VNA) and PACS Market Size by Region
8.1.1 Global Vendor Neutral Archive (VNA) and PACS Market Size by Region
8.1.2 Global Vendor Neutral Archive (VNA) and PACS Market Size Market Share by Region
8.2 North America
8.2.1 North America Vendor Neutral Archive (VNA) and PACS Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vendor Neutral Archive (VNA) and PACS Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vendor Neutral Archive (VNA) and PACS Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vendor Neutral Archive (VNA) and PACS Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vendor Neutral Archive (VNA) and PACS Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Agfa Healthcare NV
9.1.1 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Basic Information
9.1.2 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product Overview
9.1.3 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.1.4 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
9.1.5 Agfa Healthcare NV Business Overview
9.1.6 Agfa Healthcare NV Recent Developments
9.2 Dell Technologies
9.2.1 Dell Technologies Vendor Neutral Archive (VNA) and PACS Basic Information
9.2.2 Dell Technologies Vendor Neutral Archive (VNA) and PACS Product Overview
9.2.3 Dell Technologies Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.2.4 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
9.2.5 Dell Technologies Business Overview
9.2.6 Dell Technologies Recent Developments
9.3 Fujifilm Holdings Corporation
9.3.1 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Basic Information
9.3.2 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product Overview
9.3.3 Fujifilm Holdings Corporation Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.3.4 Agfa Healthcare NV Vendor Neutral Archive (VNA) and PACS SWOT Analysis
9.3.5 Fujifilm Holdings Corporation Business Overview
9.3.6 Fujifilm Holdings Corporation Recent Developments
9.4 GE Healthcare
9.4.1 GE Healthcare Vendor Neutral Archive (VNA) and PACS Basic Information
9.4.2 GE Healthcare Vendor Neutral Archive (VNA) and PACS Product Overview
9.4.3 GE Healthcare Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.4.4 GE Healthcare Business Overview
9.4.5 GE Healthcare Recent Developments
9.5 IBM Corporation
9.5.1 IBM Corporation Vendor Neutral Archive (VNA) and PACS Basic Information
9.5.2 IBM Corporation Vendor Neutral Archive (VNA) and PACS Product Overview
9.5.3 IBM Corporation Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.5.4 IBM Corporation Business Overview
9.5.5 IBM Corporation Recent Developments
9.6 Koninklijke Philips NV
9.6.1 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Basic Information
9.6.2 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product Overview
9.6.3 Koninklijke Philips NV Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.6.4 Koninklijke Philips NV Business Overview
9.6.5 Koninklijke Philips NV Recent Developments
9.7 Lexmark International
9.7.1 Lexmark International Vendor Neutral Archive (VNA) and PACS Basic Information
9.7.2 Lexmark International Vendor Neutral Archive (VNA) and PACS Product Overview
9.7.3 Lexmark International Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.7.4 Lexmark International Business Overview
9.7.5 Lexmark International Recent Developments
9.8 McKesson Corporation
9.8.1 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Basic Information
9.8.2 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product Overview
9.8.3 McKesson Corporation Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.8.4 McKesson Corporation Business Overview
9.8.5 McKesson Corporation Recent Developments
9.9 Novarad Corporation
9.9.1 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Basic Information
9.9.2 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product Overview
9.9.3 Novarad Corporation Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.9.4 Novarad Corporation Business Overview
9.9.5 Novarad Corporation Recent Developments
9.10 Siemens
9.10.1 Siemens Vendor Neutral Archive (VNA) and PACS Basic Information
9.10.2 Siemens Vendor Neutral Archive (VNA) and PACS Product Overview
9.10.3 Siemens Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.10.4 Siemens Business Overview
9.10.5 Siemens Recent Developments
9.11 TeraMedica
9.11.1 TeraMedica Vendor Neutral Archive (VNA) and PACS Basic Information
9.11.2 TeraMedica Vendor Neutral Archive (VNA) and PACS Product Overview
9.11.3 TeraMedica Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.11.4 TeraMedica Business Overview
9.11.5 TeraMedica Recent Developments
9.12 Merge Health
9.12.1 Merge Health Vendor Neutral Archive (VNA) and PACS Basic Information
9.12.2 Merge Health Vendor Neutral Archive (VNA) and PACS Product Overview
9.12.3 Merge Health Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.12.4 Merge Health Business Overview
9.12.5 Merge Health Recent Developments
9.13 BridgeHead
9.13.1 BridgeHead Vendor Neutral Archive (VNA) and PACS Basic Information
9.13.2 BridgeHead Vendor Neutral Archive (VNA) and PACS Product Overview
9.13.3 BridgeHead Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.13.4 BridgeHead Business Overview
9.13.5 BridgeHead Recent Developments
9.14 Carestream Health
9.14.1 Carestream Health Vendor Neutral Archive (VNA) and PACS Basic Information
9.14.2 Carestream Health Vendor Neutral Archive (VNA) and PACS Product Overview
9.14.3 Carestream Health Vendor Neutral Archive (VNA) and PACS Product Market Performance
9.14.4 Carestream Health Business Overview
9.14.5 Carestream Health Recent Developments
10 Vendor Neutral Archive (VNA) and PACS Regional Market Forecast
10.1 Global Vendor Neutral Archive (VNA) and PACS Market Size Forecast
10.2 Global Vendor Neutral Archive (VNA) and PACS Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vendor Neutral Archive (VNA) and PACS Market Size Forecast by Country
10.2.3 Asia Pacific Vendor Neutral Archive (VNA) and PACS Market Size Forecast by Region
10.2.4 South America Vendor Neutral Archive (VNA) and PACS Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vendor Neutral Archive (VNA) and PACS by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Vendor Neutral Archive (VNA) and PACS Market Forecast by Type (2025-2030)
11.2 Global Vendor Neutral Archive (VNA) and PACS Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
